SCHEMBL8107722

SCHEMBL8107722

CCCCc1cn(-c2c(C(=O)O)cccc2C(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cn1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 10/20 0.49
AGTR2 P50052 8/20 0.49
BRS3 P32247 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8118061 0.96 AGTR1 (0.44) AGTR1AGTR2BRS3
SCHEMBL8119230 0.94 AGTR1 (0.49) AGTR1AGTR2BRS3
SCHEMBL8122962 0.94 AGTR1 (0.55) AGTR1AGTR2
SCHEMBL8110673 0.92 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL8115333 0.92 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL8106185 0.91 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL8108798 0.91 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL6500704 0.91 AGTR1 (0.52) AGTR1AGTR2
SCHEMBL8117429 0.90 AGTR1 (0.50) AGTR1AGTR2
SCHEMBL8123036 0.90 AGTR1 (0.50) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001970-A1 DIPEPTIDE DERIVATIVES AS GROWTH HORMONE SECRETAGOGUES PFIZER INC. (US) 2000-05-24 EP disclosed
EP-0664802-B1 N-ARYLHETEROARYLALKYL 1-PHENYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 2000-03-15 EP disclosed
WO-1998058947-A1 DIPEPTIDE DERIVATIVES AS GROWTH HORMONE SECRETAGOGUES PFIZER INC. (US) 1998-12-30 WO disclosed
EP-0664802-A1 N-ARYLHETEROARYLALKYL 1-PHENYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1995-08-02 EP disclosed
WO-1994008990-A1 N-ARYLHETEROARYLALKYL 1-PHENYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1994-04-28 WO disclosed